Biomarkers as outcome predictors in subarachnoid hemorrhage-a systematic review

Biomarkers

Volumn 19, Issue 2, 2014, Pages 95-108

  Hong, Caron M ^a   Tosun, Cigdem ^a   Kurland, David B ^a   Gerzanich, Volodymyr ^a   Schreibman, David ^a   Simard, J Marc ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Critical care; Markers; Outcome; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ANIMALS; BIOLOGICAL MARKERS; HUMANS; PROGNOSIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84894514495     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.881418     Document Type: Review

References (114)

1. Badjatia N, Carpenter A, Fernandez L, et al. (2011). Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 42:2436-42.
2. Bernabeu C, Conley BA, Vary CP. (2007). Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 102:1375-88.
3. Carmeliet P, Collen D. (1998). Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Int 53:1519-49.
4. Cengiz SL, Ak A, Ustun ME, Karakose S. (2007). Lactate contents from cerebrospinal fluid in experimental subarachnoid hemorrhage, well correlate with vasospasm: ongoing and neurologic status. J Neurosurg Anesthesiol 19:166-70.
5. Chou SH, Feske SK, Atherton J, et al. (2012). Early elevation of serum tumor necrosis factor-alpha is associated with poor outcome in subarachnoid hemorrhage. J Investig Med 60:1054-8.
6. Chou SH, Feske SK, Simmons SL, et al. (2011). Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res 2:600-7.
7. Coplin WM, Longstreth Jr WT, Lam AM, et al. (1999). Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage. Arch Neurol 56:1348-52.
8. Dilraj A, Botha JH, Rambiritch V, et al. (1992). Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery 31:42-50.
9. Dunn LT, Stewart E, Murray GD, et al. (2001). The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study. Neurosurgery 48:1006-10.
10. Fassbender K, Hodapp B, Rossol S, et al. (2000). Endothelin-1 in subarachnoid hemorrhage: an acute-phase reactant produced by cerebrospinal fluid leukocytes. Stroke 31:2971-5.
11. Fassbender K, Hodapp B, Rossol S, et al. (2001). Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 70:534-7.
12. Fountas KN, Tasiou A, Kapsalaki EZ, et al. (2009). Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article. Neurosurg Focus 26:E22. doi: 10.3171/2009.2.FOCUS08311.
13. Frijns CJ, Fijnheer R, Algra A, et al. (2006a). Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. J Neurol Neurosurg Psychiatry 77:77-83.
14. Frijns CJ, Kasius KM, Algra A, et al. (2006b). Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 77:863-7.
15. Frijns CJ, Rinkel GJ, Castigliego D, et al. (2002). Endothelial cell activation after subarachnoid hemorrhage. Neurosurgery 50: 1223-9.
16. Frontera JA, Aledort L, Gordon E, et al. (2012). Early platelet activation, inflammation and acute brain injury after a subarachnoid hemorrhage: a pilot study. J Thromb Haemost 10:711-13.
17. Gao J, Wang H, Sheng H, et al. (2006). A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 4:25-31.
18. Grosskreutz CL, Anand-Apte B, Duplaa C, et al. (1999). Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 58:128-36.
19. Hardemark HG, Almqvist O, Johansson T, et al. (1989). S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction. Acta Neurochir (Wien) 99: 135-44.
20. Hassan T, Nassar M, Elhadi SM, Radi WK. (2012). Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker. Neurosurg Rev 35: 421-7.
21. Herrmann M, Vos P, Wunderlich MT, et al. (2000). Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 31:2670-7.
22. Hop JW, Rinkel GJ, Algra, A, van GJ. (1997). Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 28:660-4.
23. Ingebrigtsen T, Waterloo K, Jacobsen EA, et al. (1999). Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 45:468-75.
24. Jeon YT, Lee JH, Lee H, et al. (2012). The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 24:317-24.
25. Jung CS, Lange B, Zimmermann M, Seifert V. (2013). CSF and serum biomarkers focusing on cerebral vasospasm and ischemia after subarachnoid hemorrhage. Stroke Res Treat 2013:560305.
26. Juvela S. (2000). Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J Neurosurg 92:390-400.
27. Kacira T, Kemerdere R, Atukeren P, et al. (2007). Detection of caspase- 3, neuron specific enolase, and high-sensitivity C-reactive protein levels in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. Neurosurgery 60:674-9.
28. Kaneda K, Fujita M, Yamashita S, et al. (2010). Prognostic value of biochemical markers of brain damage and oxidative stress in postsurgical aneurysmal subarachnoid hemorrhage patients. Brain Res Bull 81:173-7.
29. Kanner AA, Marchi N, Fazio V, et al. (2003). Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97:2806-13.
30. Kassell NF, Sasaki T, Colohan AR, Nazar G. (1985). Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-72.
31. Kassell NF, Torner JC, Adams Jr HP. (1984). Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 61:225-30.
32. Kasuya H, Shimizu, T. (1989). Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J Neurosurg 71:741-6.
33. Kay A, Petzold A, Kerr M, et al. (2003a). Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: correlation with injury severity and clinical outcome. Stroke 34:637-42.
34. Kay A, Petzold A, Kerr M, et al. (2003b). Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke 34:e240-3.
35. Kaynar MY, Tanriverdi T, Kafadar AM, et al. (2004). Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. J Neurosurg 101:1030-6.
36. Kofoed K, Andersen O, Kronborg G, et al. (2007). Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11: R38.
37. Kubo Y, Ogasawara K, Kakino S, et al. (2008). Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage. Surg Neurol 69:592-6.
38. Kumar PV, Vannemreddy P, Kumar D, et al. (2011). Cardiac troponin I levels are a marker of myocardial dysfunction in subarachnoid hemorrhage and predicts poor neurologic outcome. J Louisiana State Medical Soc 163:257-60.
39. Lackner P, Dietmann A, Beer R, et al. (2010). Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke 41:2353-7.
40. Lanterna LA, Biroli F. (2009). Significance of apolipoprotein E in subarachnoid hemorrhage: neuronal injury, repair, and therapeutic perspectives - a review. J Stroke Cerebrovasc Dis 18:116-23.
41. Lanterna LA, Rigoldi M, Tredici G, et al. (2005). APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage. Neurology 64:1238-44.
42. Leung CH, Poon WS, Yu LM, et al. (2002). Apolipoprotein e genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 33: 548-52.
43. Lewis SB, Wolper R, Chi YY, et al. (2010). Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage. J Neurosci Res 88:1475-84.
44. Lindsberg PJ, Ohman J, Lehto T, et al. (1996). Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol 40:587-96.
45. Louko AM, Vilkki J, Niskakangas T. (2006). ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study. Acta Neurol Scand 114:315-19.
46. Luzzani A, Polati E, Dorizzi R, et al. (2003). Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31:1737-41.
47. Mabe H, Suzuki S, Mase M, et al. (1991). Serum neuron-specific enolase levels after subarachnoid hemorrhage. Surg Neurol 36:170-4.
48. Macdonald RL, Higashida RT, Keller E, et al. (2010). Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care 13:416-24.
49. Macdonald RL, Higashida RT, Keller E, et al. (2011). Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618-25.
50. Macdonald RL, Higashida RT, Keller E, et al. (2013). Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). Acta Neurochir Suppl 115:27-31.
51. Macdonald RL, Kassell NF, Mayer S, et al. (2008). Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, doubleblind, placebo-controlled phase 2 dose-finding trial. Stroke 39: 3015-21.
52. Mack WJ, Ducruet AF, Hickman ZL, et al. (2007). Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 61:255-60.
53. Mack WJ, Mocco J, Hoh DJ, et al. (2002). Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:71-5.
54. Manikis P, Jankowski S, Zhang H, et al. (1995). Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med 13:619-22.
55. Martinez-Morillo E, Diamandis A, Romaschin AD, Diamandis EP. (2012). Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage. PLoS One 7:e45676.
56. Masaoka H, Suzuki R, Hirata Y, et al. (1989). Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet 2:1402.
57. Mathiesen T, Edner G, Ulfarsson E, Andersson B. (1997). Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 87:215-20.
58. McGirt MJ, Lynch JR, Blessing R, et al. (2002). Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 51:1128-34.
59. Melder RJ, Koenig GC, Witwer BP, et al. (1996). During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2: 992-7.
60. Meyers PM, Connolly Jr ES. (2011). Stroke: disappointing results for clazosentan in CONSCIOUS-2. Nat Rev Neurol 7:660-1.
61. Miketic JK, Hravnak M, Sereika SM, Crago EA. (2010). Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage. Am J Crit Care 19:522-8.
62. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. (2009). Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37:1670-7.
63. Mondello S, Jeromin A, Buki A, et al. (2012). Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma 29:1096-104.
64. Mondello S, Papa L, Buki A, et al. (2011). Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care 15:R156. doi: 10.1186/cc10286.
65. Morga R, Czepko R, Dembinska-Kiec A, Danilewicz B. (2007). Assessment of the haemostatic system in patients surgically treated for ruptured cerebral aneurysm. Neurol Neurochir Pol 41: 296-305.
66. Moritz S, Warnat J, Bele S, et al. (2010). The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage. J Neurosurg Anesthesiol 22: 21-31.
67. Morris PG, Wilson JT, Dunn LT, Nicoll JA. (2004). Apolipoprotein E polymorphism and neuropsychological outcome following subarachnoid haemorrhage. Acta Neurol Scand 109:205-9.
68. Moussouttas M, Huynh TT, Khoury J, et al. (2012). Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage. Cerebrovasc Dis 33:173-81.
69. Naidech AM, Kreiter KT, Janjua N, et al. (2005). Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 112:2851-6.
70. Nakahara T, Tsuruta R, Kaneko T, et al. (2009). High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Neurocrit Care 11:362-8.
71. Nilsson OG, Brandt L, Ungerstedt U, Saveland H. (1999). Bedside detection of brain ischemia using intracerebral microdialysis: subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery 45:1176-84.
72. Niskakangas T, Ohman J, Niemela M, et al. (2001). Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study. Stroke 32:1181-4.
73. Nissen JJ, Mantle D, Blackburn A, et al. (2000). The selectin superfamily: the role of selectin adhesion molecules in delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. Acta Neurochir 76:55-60.
74. Nylen K, Csajbok LZ, Ost M, et al. (2006). CSF-neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci Lett 404:132-6.
75. Nylen K, Csajbok LZ, Ost M, et al. (2007). Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke 38:1489-94.
76. Oconnor E, Venkatesh B, Mashongonyika C, et al. (2004). Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care 32:465-70.
77. Oertel M, Schumacher U, McArthur DL, et al. (2006). S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. J Clin Neurosci 13: 834-40.
78. Olsson AK, Dimberg A, Kreuger J, et al. (2006). VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7: 359-71.
79. Ostergaard JR, Kristensen BO, Svehag SE, et al. (1987). Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg 66:891-7.
80. Ostrowski RP, Colohan AR, Zhang JH. (2006). Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 28: 399-414.
81. Persson L, Hardemark H, Edner G, et al. (1988). S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage. Acta Neurochir (Wien) 93: 116-22.
82. Petzold A, Keir G, Kay A, et al. (2006). Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 77: 753-9.
83. Ramappa P, Thatai D, Coplin W, et al. (2008). Cardiac troponin-I: a predictor of prognosis in subarachnoid hemorrhage. Neurocritical Care 8:398-403.
84. Reinhart K, Meisner M. (2011). Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 27:253-63.
85. Romero FR, Bertolini EF, Figueiredo EG, Teixeira MJ. (2012). Serum Creactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage. Arq Neuropsiquiatr 70:202-5.
86. Sanchez-Pena P, Pereira AR, Sourour NA, et al. (2008). S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 36:2267-73.
87. Sandhu R, Aronow WS, Rajdev A, et al. (2008). Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Am J Cardiol 102:632-4.
88. Sarrafzadeh A, Haux D, Sakowitz O, et al. (2003). Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke 34:1382-8.
89. Schick U, Dohnert J, Meyer JJ, et al. (2003). Prognostic significance of SSEP, BAEP and serum S-100b monitoring after aneurysm surgery. Acta Neurol Scand 108:161-9.
90. Schmid-Elsaesser R, Kunz M, et al. (2006). Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 58: 1054-65.
91. Schuiling WJ, Dennesen PJW, Tans J, et al. (2005). Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 76: 1565-9.
92. Seifert V, Loffler BM, Zimmermann M, et al. (1995). Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82:55-62.
93. Solenski NJ, Haley Jr EC, Kassell NF, et al. (1995). Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 23:1007-17.
94. Sozen T, Tsuchiyama R, Hasegawa Y, et al. (2009). Role of interleukin- 1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 40:2519-25.
95. Staub F, Graf R, Gabel P, et al. (2000). Multiple interstitial substances measured by microdialysis in patients with subarachnoid hemorrhage. Neurosurgery 47:1106-15.
96. Stranjalis G, Korfias S, Psachoulia C, et al. (2007). The prognostic value of serum S-100b protein in spontaneous subarachnoid haemorrhage. Acta Neurochir (Wien) 149:231-8.
97. Suarez JI, Tarr RW, Selman WR. (2006). Aneurysmal subarachnoid hemorrhage. N Engl J Med 354:387-96.
98. Suzuki H, Sato S, Suzuki Y, et al. (1990). Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage. Ann Med 22:233-6.
99. Suzuki M, Kudo A, Otawara Y, et al. (1997). Fibrinolytic activity in the CSF and blood following subarachnoid haemorrhage. Acta Neurochir (Wien) 139:1152-4.
100. Tang J, Zhao J, Zhao Y, et al. (2003). Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surg Neurol 60:391-6.
101. Taub PR, Fields JD, Wu AH, et al. (2011). Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage. Neurocrit Care 15:13-18.
102. Terao Y, Takada M, Tanabe T, et al. (2007). Microalbuminuria is a prognostic predictor in aneurysmal subarachnoid hemorrhage. Intensive Care Med 33:1000-6.
103. Testai FD, Aiyagari V, Hillmann M, et al. (2011). Proof of concept: endogenous antiangiogenic factors predict the occurrence of symptomatic vasospasm post subarachnoid hemorrhage. Neurocrit Care 15: 416-20.
104. Ungerstedt U, Rostami E. (2004). Microdialysis in neurointensive care. Curr Pharm Des 10:2145-52.
105. Vincent JL, Donadello K, Schmit X. (2011). Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin 27:241-51.
106. Vos PE, Lamers KJ, Hendriks JC, et al. (2004). Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62:1303-10.
107. Vos PE, van GM, Beems T, et al. (2006). Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur J Neurol 13:632-8.
108. Wang HC, Lin WC, Yang TM, et al. (2011). The association between symptomatic delayed cerebral infarction and serum adhesion molecules in aneurysmal subarachnoid hemorrhage. Neurosurgery 68: 1611-17.
109. Webb DJ, Monge JC, Rabelink TJ, Yanagisawa M. (1998). Endothelin: new discoveries and rapid progress in the clinic. Trends Pharmacol Sci 19:5-8.
110. Weiss N, Sanchez-Pena P, Roche S, et al. (2006). Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology 104:658-66.
111. Wiesmann G, Missler U, Hagenström H, Gottmann D. (1997). S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 139:1155-60.
112. Yarlagadda S, Rajendran P, Miss JC, et al. (2006). Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocritical Care 5:102-7.
113. Zanier ER, Refai D, Zipfel GJ, et al. (2011). Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 82: 157-9.
114. Zubkov AY, Rollins KS, Parent AD, et al. (2000). Mechanism of endothelin-1-induced contraction in rabbit basilar artery. Stroke 31: 526-33.